Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,011 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
[Cost effectiveness of pravastatin in secondary coronary prevention in patients with myocardial infarct or unstable angina in Germany. An analysis on the basis of the LIPID trial].
Szucs TD, Berger K, März W, Schäfer JR. Szucs TD, et al. Among authors: berger k. Herz. 2000 Aug;25(5):487-94. doi: 10.1007/pl00001961. Herz. 2000. PMID: 10992997 German.
[Cost-of-illness study in patients suffering from atopic eczema in Germany].
Ehlken B, Möhrenschlager M, Kugland B, Berger K, Quednau K, Ring J. Ehlken B, et al. Among authors: berger k. Hautarzt. 2005 Dec;56(12):1144-51. doi: 10.1007/s00105-005-0953-2. Hautarzt. 2005. PMID: 15933866 German.
[Cost structure of hepatitis B infection].
Szucs TD, Müller EI, Berger K. Szucs TD, et al. Among authors: berger k. Fortschr Med. 1997 Feb 10;115(4):47-8. Fortschr Med. 1997. PMID: 9157046 German. No abstract available.
[Cost effectiveness of ACE inhibition in therapy of chronic heart failure in Switzerland: evaluation based on the SOLVD study].
Szucs TD, Goedde M, Berger K, Kiowski W. Szucs TD, et al. Among authors: berger k. Schweiz Med Wochenschr. 1997 Jul 22;127(29-30):1234-41. Schweiz Med Wochenschr. 1997. PMID: 9333933 Clinical Trial. German.
[Cost effectiveness of captopril after myocardial infarct; comment].
Szucs T, Berger K, Schulte-Hillen J, Kleber FX. Szucs T, et al. Among authors: berger k. Med Klin (Munich). 1996 Feb 15;91(2):112-8. Med Klin (Munich). 1996. PMID: 8850108 Clinical Trial. German.
[Economic aspects of drug therapy exemplified by pravastatin. A socioeconomic analysis of cholesterol synthase enzyme inhibition in coronary heart disease patients].
Berger K, Klose G, Szucs TD. Berger K, et al. Med Klin (Munich). 1997 Jun 15;92(6):363-9. doi: 10.1007/BF03044779. Med Klin (Munich). 1997. PMID: 9297070 Review. German.
[Costs and cost-effectiveness of Eptifibatide in the treatment of coronary ischemic syndromes. An analysis based on the PURSUIT study].
Szucs TD, Schwenkglenks M, Berger K, Karsch K. Szucs TD, et al. Among authors: berger k. Z Kardiol. 2003 Mar;92(3):236-44. doi: 10.1007/s00392-003-0908-5. Z Kardiol. 2003. PMID: 12658471 Clinical Trial. German.
[Pharmacoeconomic evaluation of pravastatin in the secondary prevention of coronary heart disease in patients with average cholesterol levels. An analysis for Germany based on the CARE study].
Szucs TD, Guggenberger G, Berger K, März W, Schäfer JR. Szucs TD, et al. Among authors: berger k. Herz. 1998 Aug;23(5):319-29. doi: 10.1007/BF03044365. Herz. 1998. PMID: 9757381 Clinical Trial. German.
Cost of bacterial vaginosis in pregnancy. Decision analysis and cost evaluation of a clinical study in Germany.
Müller E, Berger K, Dennemark N, Oleen-Burkey M. Müller E, et al. Among authors: berger k. J Reprod Med. 1999 Sep;44(9):807-14. J Reprod Med. 1999. PMID: 10509306
Clopidogrel versus aspirin in patients with atherothrombosis: CAPRIE-based calculation of cost-effectiveness for Germany.
Berger K, Hessel F, Kreuzer J, Smala A, Diener HC. Berger K, et al. Curr Med Res Opin. 2008 Jan;24(1):267-74. doi: 10.1185/030079908x253762. Curr Med Res Opin. 2008. PMID: 18053318
1,011 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page